Alim M. Aikembayev
1, Larissa Lukhnova, Gulnara Temiraliyeva, Tatyana Meka-Mechenko, Yerlan Pazylov, Sarkis Zakaryan, Georgiy Denissov, W. Ryan Easterday, Matthew N. Van Ert
2, Paul Keim, Stephen C. Francesconi, Jason K. Blackburn
3, Martin Hugh-Jones

, and Ted Hadfield
Author affiliations: Kazakhstan Scientific Center for Quarantine and Zoonotic Diseases, Almaty, Kazakhstan (A.M. Aikembayev, L. Lukhnova, G. Temiraliyeva, T. Meka-Mechenko, Y. Pazylov, S. Zakaryan, G. Denissov); Northern Arizona University, Flagstaff, Arizona, USA (W.R. Easterday, P. Keim); Midwest Research Institute, Palm Bay, Florida, USA (M.N. Van Ert, T. Hadfield); The Translational Genomics Research Institute, Phoenix, Arizona, USA (P. Keim); Naval Medical Research Center, Silver Spring, Maryland, USA (S.C. Francesconi); California State University, Fullerton, California, USA (J.K. Blackburn); Louisiana State University, Baton Rouge, Louisiana, USA (M. Hugh-Jones);
Main Article
Table 1
Outcomes for 1,765 human patients in mapped anthrax outbreak areas, Kazakhstan, 1937–2005
| Status |
Number |
| Recovered |
1,541 |
| Deceased |
75 |
| Lost contact |
17 |
| No data/unknown |
132 |
Main Article
Top of Page